News

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...
Domain Associates LLC Raises 8th Venture Fund PRINCETON, N.J. - (Business Wire) ... LP, a $500 million venture capital fund devoted exclusively to the life sciences industry. ...
New Enterprise Associates, Apax Partners, Domain Associates, Montagu Newhall Global Partners and Oak Investment Partners Esprit is focused on urology and women's health care specialty markets ...
BRANFORD, Conn., Jan. 7, 2013 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. is pleased to announce $21 million in new Series C financing from U.S. venture capital firm Domain Associates, LLC ...
On August 13, 2018, Vice Chancellor Travis Laster of the Delaware Court of Chancery ordered Domain Associates, LLC (“Plaintiffs,” “Domain,” or the “Firm”), a venture capital firm, to ...
Domain Associates has found a potential answer to some of those problems in the form of a $760 million tie-up with Rusnano, the Russian government's state-owned venture capital firm. Under the deal, ...
Domain Associates LLC, a key source of funding for Orange County medical device and drug startups, is moving its West Coast offices from Laguna Niguel to Carmel Valley in San Diego County. One notable ...
Domain Associates’ Laguna Niguel office made a big splash in San Diego County. Domain and Prospect Venture Partners of Palo Alto led a $78 million first round of funding for San Diego-based Verus ...
Axial Biotherapeutics is the latest microbiome firm to emerge. Private and venture capital investors, including Longwood Fund and Domain Associates, have put an initial $19 million into the ...
The same month that researchers published confirmatory findings in Nature Biotechnology (NBT) that rising-star, emerging markets do not represent much of a near-term challenge to U.S. drug developers, ...